# Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma

> **NCT01765036** · NA · COMPLETED · sponsor: **Société Française d'Endoscopie Digestive** · enrollment: 100 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **DRUG:** SonoVue®

## Key facts

- **NCT ID:** NCT01765036
- **Lead sponsor:** Société Française d'Endoscopie Digestive
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01765036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01765036, "Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01765036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*